BIT
SUPN icon

BlackRock Institutional Trust’s Supernus Pharmaceuticals SUPN Stock Holding History

BlackRock Institutional Trust’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$31M Buy
1,228,844
+79,600
+7% +$1.78M ﹤0.01% 1644
2016
Q3 		$28.4M Buy
1,149,244
+165,346
+17% +$3.74M ﹤0.01% 1638
2016
Q2 		$20M Buy
983,898
+98,057
+11% +$1.74M ﹤0.01% 1847
2016
Q1 		$13.5M Buy
885,841
+12,073
+1% +$158K ﹤0.01% 2072
2015
Q4 		$11.7M Buy
873,768
+32,103
+4% +$497K ﹤0.01% 2221
2015
Q3 		$11.8M Buy
841,665
+235,695
+39% +$4.38M ﹤0.01% 2177
2015
Q2 		$10.3M Buy
605,970
+230,538
+61% +$3.28M ﹤0.01% 2390
2015
Q1 		$4.54M Buy
375,432
+98,299
+35% +$929K ﹤0.01% 2791
2014
Q4 		$2.3M Sell
277,133
-3,194
-1% -$26.8K ﹤0.01% 3043
2014
Q3 		$2.44M Sell
280,327
-25,413
-8% -$230K ﹤0.01% 2990
2014
Q2 		$3.35M Buy
305,740
+111,669
+58% +$995K ﹤0.01% 2953
2014
Q1 		$1.74M Buy
194,071
+46,045
+31% +$424K ﹤0.01% 3218
2013
Q4 		$1.12M Sell
148,026
-7,416
-5% -$51.9K ﹤0.01% 3365
2013
Q3 		$1.14M Buy
155,442
+6,817
+5% +$45.8K ﹤0.01% 3325
2013
Q2 		$956K Buy
+148,625
New +$875K ﹤0.01% 3340

Other funds holding SUPN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

BlackRock Institutional Trust's SUPN Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Supernus Pharmaceuticals (SUPN) stake by 6.9% in Q4 2016, buying an estimated $1.78M and bringing the position to 1,228,844 shares worth $31M. The position accounts for ﹤0.01% of the portfolio, ranked #1644.

BlackRock Institutional Trust first reported a position in SUPN in Q2 2013 and has held it in 15 quarters since. 234 funds tracked by Wall St. Rank hold SUPN as of Q4 2016.

  • BlackRock Institutional Trust held 1,228,844 shares of Supernus Pharmaceuticals worth $31M as of Q4 2016.
  • BlackRock Institutional Trust bought 79,600 Supernus Pharmaceuticals shares in Q4 2016, an estimated $1.78M.
  • Supernus Pharmaceuticals made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1644 holding.
  • BlackRock Institutional Trust first reported a position in Supernus Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • 234 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.